Egle Gineikiene
Overview
Explore the profile of Egle Gineikiene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borutinskaite V, Zucenka A, Vitkeviciene A, Stoskus M, Kaupinis A, Valius M, et al.
Front Genet
. 2022 May;
13:821676.
PMID: 35495123
Acute myeloid leukemia (AML) is an aggressive, heterogeneous group of malignancies with different clinical behaviors and different responses to therapy. For many types of cancer, finding cancer early makes it...
2.
Norvilas R, Batiuskaite R, Dirse V, Semaskeviciene R, Gineikiene E, Stoskus M, et al.
Leuk Res
. 2022 Mar;
116:106825.
PMID: 35339799
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically diverse disease characterized by a heterogeneous profile of genetic lesions. Recent transcriptome studies identified a number of new T-ALL-related gene fusions....
3.
Norvilas R, Dirse V, Semaskeviciene R, Mickeviciute O, Gineikiene E, Stoskus M, et al.
BMC Cancer
. 2021 Mar;
21(1):326.
PMID: 33781217
Background: ABL-class and JAK-STAT signaling pathway activating alterations have been associated with both a poor post-induction minimal residual disease (MRD) response and an inferior outcome in B-cell acute lymphoblastic leukemia...
4.
Zucenka A, Pileckyte R, Trociukas I, Peceliunas V, Vaitekenaite V, Maneikis K, et al.
Eur J Haematol
. 2020 Sep;
106(1):105-113.
PMID: 32997830
Objectives And Methods: We conducted a retrospective analysis to evaluate the outcomes of 28 heavily pretreated (median 3 (2-6) treatment lines, sixteen (57%) allotransplanted) relapsed/refractory acute myeloid leukemia patients who...
5.
Vitkeviciene A, Skiauteryte G, Zucenka A, Stoskus M, Gineikiene E, Borutinskaite V, et al.
J Oncol
. 2020 Sep;
2020:1834190.
PMID: 32952555
[This corrects the article DOI: 10.1155/2019/6179573.].
6.
Vitkeviciene A, Skiauteryte G, Zucenka A, Stoskus M, Gineikiene E, Borutinskaite V, et al.
J Oncol
. 2019 Aug;
2019:6179573.
PMID: 31396278
Acute promyelocytic leukemia (APL) is characterized by translocation, which causes the blockage of promyelocyte differentiation. Conventional treatment with Retinoic acid and chemotherapeutics is quite satisfactory. However, there are still patients...
7.
Buivydiene A, Liakina V, Kashuba E, Norkuniene J, Jokubauskiene S, Gineikiene E, et al.
Medicina (Kaunas)
. 2018 Oct;
54(5).
PMID: 30344298
: The hepatitis C virus (HCV) is the major causative agent of hepatocellular carcinoma (HCC) in the western world. The efficacy of surveillance programs for early detection of HCC is...
8.
Dirse V, Norvilas R, Gineikiene E, Matuzeviciene R, Griskevicius L, Preiksaitiene E
Leuk Lymphoma
. 2017 Aug;
59(4):1022-1024.
PMID: 28776427
No abstract available.
9.
Dirse V, Gineikiene E, Zvirblis T, Bertasiute R, Paulsson K, Griskevicius L
Leuk Lymphoma
. 2016 Mar;
57(11):2716-9.
PMID: 26999635
No abstract available.
10.
Dirse V, Bertasiute A, Gineikiene E, Zvirblis T, Dambrauskiene R, Gerbutavicius R, et al.
Genes Chromosomes Cancer
. 2015 Feb;
54(5):326-33.
PMID: 25706938
Adult acute lymphoblastic leukemia (ALL) is characterized by a high frequency of abnormal karyotypes some of which are related to outcome. Single nucleotide polymorphism (SNP) array analysis provides a highly...